Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: 70 year old white male with a history of cad with increasing episodes of chest tightness. major surgical or invasive procedure: cabgx3 (lima->lad, svg->pda, svg->ramus) history of present illness: this 70 year old white male has a history of cad and had been cathed in . he needed intervention at that time, but was waiting for the drug eluting stents. he has been followed by dr. who felt he needed a new cath as he was having increasing chest tightness. he was admitted for the cooling study. he reportedly was turned down for a cabg in because of obesity. past medical history: cad niddm htn hypercholesteremia cri chf anemia s/p pacemaker placement for sss retinopathy- s/p laser x 3 chronic le edema social history: he lives alone, does not smoke cigarettes, and does not drink alcohol. family history: +cad physical exam: gen: obese, elderly, white male in nad afeb, hr 60, bp 114/68, rr 10, 280 lbs. heent: n/c, a/t, eomi, perla, oropharynx benign. neck: supple, from, no lymphadenopathy or thyromegaly, carotids 2+=bilat. lungs: clear to a+p cv: rrr w/out r/g/m abd: obese, soft, nontender, without masses or hepatosplenomegaly. ext: bilat. le edema with venouse stasis changes. pulses 1+ = bilat. neuro: non-focal. pertinent results: hematology complete blood count wbc rbc hgb hct mcv mch mchc rdw plt ct 07:05am 9.8 3.58* 11.3* 33.7* 94 31.6 33.5 15.1 309 basic coagulation plt ct 07:05am 309 chemistry renal & glucose glucose urean creat na k cl hco3 angap 07:05am 113* 101* 3.2* 137 4.7 95* 27 20 antibiotics vanco 07:05am 16.1* brief hospital course: the patient was admitted on and was enrolled in the cooling study for renal protection during cardiac cath. he had an mi by enzymes on admission. he had the catheterization on and it revealed: a 50-60% stenosis of the lad, 90% diagonal lesion, 80% proximal lcx stenosis, and a 90% rca lesion. his ef is 20%. during the cath. he became hypotensive and bradycardic and required atropine and dopamine. he had an iabp placed and cardiac surgery was consulted for high risk cabg. he then developed ologuric renal failure and responded to high doses of lasix. on he underwent cabgx3 with lima to the lad, svg to the pda and ramus. he was transferred to the csru on epi, lido, and propofol in stable condition. he had some bleeding on the post op night and required 3u prbc, 2 of platelets, and 1 of cryo. he had decreased urine output and was started on a lasix drip and natracor. he continued to require these drips for several days and remained intubated until pod#3. his creat. was between 3.2 and 4, but he continued to have adequate urine output. his iabp was d/c'd on pod#1. he slowly improved and was transferred to the floor on pod#7. he developed cellulitis on his l leg and has been treated with vanco. he continued to progress and was discharged to rehab on pod# 10. medications on admission: glipizide 10 mg. po qd hydralazine 10 mg. po qd coreg 6.25 mg. po qd feso4 325 mg. po qd mvi 1 po qd ntg patch lasix 80 mg. po qd asa 81 mg. po qd plavix 75 mg po qd colace 100 mg. po bid zocor 20 mg. po qd discharge medications: 1. amiodarone hcl 200 mg tablet sig: two (2) tablet po bid (2 times a day) for 5 days: then decrease to amiodorone 400 mg po qd for 1 week, then decrease to 200 mg po qd. 2. glipizide 5 mg tablet sig: two (2) tablet po qd (once a day). 3. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day. 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 5. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po qd (once a day). 6. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. 7. metoprolol tartrate 25 mg tablet sig: 0.5 tablet po bid (2 times a day). 8. lasix 40 mg tablet sig: 1.5 tablets po three times a day. 9. vancomycin hcl 10 g recon soln sig: one (1) gram intravenous prn (as needed) as needed for level <15 for 2 weeks. 10. zocor 20 mg tablet sig: one (1) tablet po once a day. 11. ferrous sulfate 325 (65) mg capsule, sustained release sig: one (1) capsule, sustained release po once a day. discharge disposition: extended care facility: & rehab center - discharge diagnosis: coronary artery disease. niddm chf htn hypercholesterolemia cri retinopathy sss-s/p pacer placement discharge condition: good. discharge instructions: follow medications on discharge instructions. you may not drive for 4 weeks. you may not lift more than 10 lbs. for 3 months. you should shower, let water flow over wounds, pat dry with a towel. followup instructions: make an appointment with dr. for 1-2 weeks. make an appointment with dr. 1 week. make an appointment with dr. for 4 weeks. procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters (aorto)coronary bypass of two coronary arteries hemodialysis implant of pulsation balloon angiocardiography of right heart structures transfusion of packed cells transfusion of platelets injection or infusion of nesiritide diagnoses: subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia mitral valve disorders other postoperative infection congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified hemorrhage complicating a procedure cellulitis and abscess of leg, except foot surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cardiac pacemaker in situ examination of participant in clinical trial 

Answer: The patient is high likely exposed to